Current status: 886 hESC lines, 3431 hiPSC lines, and 109 clinical studies, and 449 certificates
Monthly statistic from Jan 1, 2023
Posted on January 1, 2023
| total lines | 4317 |
| hESC lines | 886 |
| hiPSC lines | 3431 |
| derivation countries | 44 |
| projects | 256 |
| providers | 772 |
| clinical studies | 109 |
| subclones | 1921 |
| certificates | 449 |
| cell line certificates | 319 |
| project certificates | 130 |